The Valley Desk

NCT05086315 · Interventional trial

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Acute Lymphocytic Leukaemia, Acute Myeloid Leukaemia Refractory, Blastic Plasmacytoid Dendritic Cell Neoplasia, Myelodysplastic Syndromes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov